Unknown

Dataset Information

0

PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.


ABSTRACT: Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and one of the most aggressive cancers. PARP-1 is a nuclear protein involved in multiple facets of DNA repair and transcriptional regulation. In this study we dissected the action of PARP inhibition in different GBM cell lines with either functional or mutated PTEN that confers resistance to diverse therapies. In PTEN mutant cells, PARP inhibition induced a severe genomic instability, exacerbated homologous recombination repair (HR) deficiency and down-regulated the Spindle Assembly Checkpoint (SAC) factor BUBR1, leading to mitotic catastrophe (MC). EGFR gene amplification also represents a signature of genetic abnormality in GBM. To more effectively target GBM cells, co-treatment with a PARP inhibitor and an EGFR blocker, erlotinib, resulted in a strong suppression of ERK1/2 activation and in vivo the combined effect elicited a robust reduction in tumour development. In conclusion, PARP inhibition targets PTEN-deficient GBM cells through accentuation of SAC repression and aggravation of HR deficiency, leading to the induction of genomic instability and eventually deriving to mitotic catastrophe (MC); the inhibition of PARP and co-treatment with an inhibitor of pro-survival pathways strongly retarded in vivo gliomagenesis.

SUBMITTER: Majuelos-Melguizo J 

PROVIDER: S-EPMC4467115 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.

Majuelos-Melguizo Jara J   Rodríguez María Isabel MI   López-Jiménez Laura L   Rodríguez-Vargas Jose M JM   Martí Martín-Consuegra Juan M JM   Serrano-Sáenz Santiago S   Gavard Julie J   de Almodóvar J Mariano Ruiz JM   Oliver F Javier FJ  

Oncotarget 20150301 7


Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and one of the most aggressive cancers. PARP-1 is a nuclear protein involved in multiple facets of DNA repair and transcriptional regulation. In this study we dissected the action of PARP inhibition in different GBM cell lines with either functional or mutated PTEN that confers resistance to diverse therapies. In PTEN mutant cells, PARP inhibition induced a severe genomic instability, exacerbated homologous recombina  ...[more]

Similar Datasets

| S-EPMC6600191 | biostudies-literature
| S-EPMC4135522 | biostudies-literature
| S-EPMC2176173 | biostudies-other
| S-EPMC6088797 | biostudies-literature
| S-EPMC6830099 | biostudies-literature
| S-EPMC8547927 | biostudies-literature
| S-EPMC9066363 | biostudies-literature
| S-EPMC8458481 | biostudies-literature
| S-EPMC3130665 | biostudies-literature
| S-EPMC5834544 | biostudies-literature